Latest filingOct 06, 2026Most recent Form 4
PTHS
Pelthos Therapeutics Inc.
Insider activity for last month from 09/07 to 10/07. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$44.9k3 sells
Net open-market-$44.9k3 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly purchases, sales and code-A awards Buys Sells Awards / grants (A)
Code A includes awards, grants and other acquisitions; these are not open-market buys.
Distinct insiders active
Reporting-owner CIKs by month · peak Oct 2026 (3)Sep 2026Oct 2026
Top insiders
By absolute net value across the selected period- GP-$16.9k
- PM-$16.5k
- FM-$11.6k
Filing detail checks
Secondary metrics for the selected periodTransaction codes
By Form 4 transaction code in selected period3transactionstxns
- S · Open-market sells · dominant3 · 100%
Activity by reported role
A joint filing can contribute to multiple roles3transactionstxns
- Director · dominant3 · 100%
Reported Holdings After
Separated by insider, security, and ownership type
Pauls MatthewCommon Stock · Direct
13,578Oct 02, 2026
Friedberg Ezra MCommon Stock · Direct
80,484Oct 02, 2026
Greenleaf PeterCommon Stock · Direct
23,087Oct 02, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redSep 07 → Oct 07
LessMore
Filing-only signals
Deterministic matches in the selected period
PTHS transaction history
Filters apply within this company and selected period by defaultLatest insider transactions
Form 4 filings from last month. Click any column to sort; click it again to flip the order.
| ID | Ticker | Insider | Role | Type | Shares | Value | Code | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|
| #239368 | PTHS | Greenleaf Peter | DIR | sale10b5-1 | 797 | -$16.8k | S | 10/06 | 10/02 |
| #239367 | PTHS | Friedberg Ezra M | DIR | sale10b5-1 | 558 | -$11.5k | S | 10/06 | 10/02 |
| #239366 | PTHS | Pauls Matthew | DIR | sale10b5-1 | 786 | -$16.5k | S | 10/06 | 10/02 |
Pelthos Therapeutics Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Pelthos Therapeutics Inc.?
Greenleaf Peter, Friedberg Ezra M, Pauls Matthew.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
Greenleaf Peter reported a sale on Oct 02, 2026 valued at $16.8k. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $44,938.52. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.